Boiron SA is a pharmaceutical company based in France with a focus on homeopathic products. With a Risk Rating Score of 30.3, it is considered to be high risk. Boiron's revenue is split between nonproprietary homeopathic medicines and over-the-counter specialties. The company's products are sold in France, Europe, North America, and other countries. Some of its popular products include Oscillococcinum, Stodal, and Sedatif PC. Boiron emphasizes ESG practices to ensure environmental sustainability and good governance.